News and Trends 2 Sep 2015
Arderlyx’s ‘hot potato’: Sanofi changes its mind about €175M pre-clinical research deal
Paris based Sanofi has pulled out of a €176M deal with Californian clinical stage biotech Ardelyx. A licensing deal for a program of pre-clinical candidates treating renal diseases and IBS-C, similar…